MedPath

A comparative study of three different doses of nalbuphine as an adjuvant to bupivacaine in suprascapular nerve block for postoperative analgesia in arthroscopic shoulder surgery

Phase 3
Recruiting
Conditions
Anaesthesia
Registration Number
PACTR202001596903715
Lead Sponsor
faculty of medicine . menofia university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

ASA physical status I-IIl

Exclusion Criteria

obesity ,
allergy to local anesthetic,
coagulopathy
presence of infection at the site of the block.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
result related to the VAS score
Secondary Outcome Measures
NameTimeMethod
: side effects (nausea and vomiting),additional analgesic requirements,and Ramsey Sedation Scores (RSS) will recorded. RSS>or= 5 will considered excessive sedation
© Copyright 2025. All Rights Reserved by MedPath